Upload
patrick-joseph-bonavitacola
View
216
Download
0
Embed Size (px)
Citation preview
8/7/2019 cancer final review
1/31
Cancer Concepts Winter, 2011
Final Review
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
2/31
What Well Try to Cover:ImportantPoints to Know
What agents can cause cancer? How do cancer cells develop from normal cells?
What is the difference between hyperplasia, metaplasia, dysplasia, carcinoma in situ,
invasive cancer, and neoplasia?
What is an oncogene? Know some examples of oncogenes and how they function.
What is a tumor suppressor gene? Know some examples of tumor suppressor genesand how the function.
What pathologic changes do cells undergo as they transform from normal to cancer?
What are protein kinases?
What is involved in the process of metastasis?
a s ang ogenes s an w y o cancers nee Do cancer metastases pop up randomly? If not, know some sites that some tumors like
to go to.
What are the ma or reasons that sur er is used when a roachin cancer?
What are the major reasons that radiation is used when approaching cancer?
What are the major reasons that drugs are used when approaching cancer?CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
3/31
What Well Try to Cover:ImportantPoints to Know continued
Have a general understanding of chemotherapy drugs by class alkylators, anti-
metabolites, topoisomerase inhibitors, microtubule binding drugs, platinum
analogues, immune therapies, antibodies, tyrosine kinase inhibitors, others
What is the role of palliative care in cancer treatment? What interventions work to revent cancer? How do the work?
What cancer screening techniques are effective? What makes a cancer screen an
effective screen?
What is the difference between stage and grade of cancer? Have a general sense of
s ages o cancer How is pediatric oncology different from adult oncology?
What long term health issues might survivors of cancer have to deal with?
How can ou explain differences in the incidence of cancer around the world?
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
4/31
Agents That Cause Cancer
Chemical Tobacco, Solvents, Pesticides
Physical Asbestos, Chronic Irritation
Radiation UV, Ionizing Viral HPV, HIV, EBV, HTLV-I
Bacterial H.Pylori
Parasitic Schistosomes, Liver Flukes
Think about how these cause cancer!
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
5/31
ow o ancer e s eve opFrom Normal Cells?
Acquisition of Genetic Changes
Loss of Tumor Suppressor Function
Common TP53, Rb
Common TEL, EGFR, HER2, KRAS, MYC, etc.
Mor holo ic Chan es
Normal Hyperplasia Dysplasia CIS
Invasion
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
6/31
at s t e erence etweenhyperplasia, metaplasia, dysplasia,
, ,and neoplasia?
yperp as a ncrease n um er o e s
Metaplasia Transformation of One Cell Type Into
Another Dysplasia Abnormal Development of Cells
Carcinoma in situMalignant Cells That Have NotInvaded Into Tissue
Invasive Cancer Malignant Cells That Have InvadedInto Tissue and Can Spread Further
Neo lasia New Cell Growth Does Not NecessarilRefer to Benign or Malignant
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
7/31
What is an oncogene?Know some examples of oncogenes
an ow t ey unct on.-
Normal Cell Growth
Normal Functions:
Growth Factors (sisB Chain of PDGF)
Receptors (erb-2HER2, EGFR)
Intracellular Signal Transduction (src, abl, KRAS)
Nuclear Transcription Factors (myc, hox)
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
8/31
Know some examples of tumor
function.
Normal Function Blocks Cell Proliferation
Normal Function Leads To DNA Repair Normal Function Leads to Apoptosis
Examples Rb, TP53, APC
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
9/31
undergo as they transform from
Morphologic Changes
Normal Hyperplasia Dysplasia CIS
Invasion
Pleomorphism
Condensed Chromatin
Loss of Polarit
Anchorage Independent Growth
Loss of Contact Inhibition CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
10/31
What Are Protein Kinases?
Kinases add phosphate (PO3=) to proteins
acids that are phosphorylated
Lar e MW=80 char ed PO = inducesconformational change on protein
Conformational change affects protein
function
ATP or GTP are PO3= donors
Protein kinases are drug targetsCC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
11/31
What is involved in the process ofmetastasis?
Cellular DiscohesionCells arenormally anchored to basementmembranes, the extra-cellular matrix, and adjacent cells. These
.
Invasion Through Basement Membrane The basement membrane mustbe destroyed. This will require enzymes. To get through the basement
membrane, theremust be cell motility. .
Survival in Blood/Lymph The cancer cell must avoid immune surveillance
Exit From Blood/Lymphatic Vessel See Invasion intoblood/lymphaticvessel
Growth in Foreign Soil Metastasis necessarily means the ability to growin an environment that is foreign to the one the cell originated in. Theremust be an ability to tolerate and thrive in new conditions.
Recruitment of New Vasculature In the absence of blood vessels, growtho a co ony o ce s s m e y e us on o oxygen an nu r en s.
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
12/31
a s ang ogenes s an w y ocancers need it?
450 m Hepatoma Cell
Spheroid
Green Cells At Rim Are Viable
Red Cells in Center are
Necrotic
NO Blood Flow = NO Life
Molecular Therapy(2009) 17 8, 14041410CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
13/31
cancers need it?
Degradation of Basement
Membrane of Existing
Vessel
Migration of Endothelial
Cells into Interstitium
Endothelial Cell Proliferation
Lumen Formation
Generation of New
Basement Membrane
Fusion of Newly Formed
VesselsCC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
14/31
Do cancer metastases pop uprandomly? If not, know some sites
a some umors e o go o.
Cancer Metastases Do NOT Appear at Random
Preferred Sites of Spread for Selected Cancers:
Lung Cancer: Bones, Liver, Adrenal Glands, Brain
, , ,
Colon Cancer: Liver, Abdominal Cavity, Lungs
Prostate Cancer: Bones
Pancreatic Cancer: Liver, Abdominal Cavity Renal Cell Carcinoma: Lungs, Bones, Brain
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
15/31
at are t e ma or reasons t atsurgery is used when approaching
Biopsy for Diagnosis
Complete Resection for Cure
R0: Complete Resection, Negative Margins : ross y omp e e esec on,
Microscopically Positive Margins
R2: Grossly Incomplete Resection
Metastatectomy Possibly for ?Cure?
Palliation Relief of Obstruction, Bleeding, Pain, etc.
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
16/31
What are the major reasons thatradiation isused when approaching
cancer? Radical Radiation for Cure
Adjuvant Radiation After Surgery
Improve Local Control Improve Survival
Palliative Radiation
Control Bleeding
O en Airwa s
?Prolong Life? (Cranial Radiation for Mets)
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
17/31
at are t e ma or reasons t at rugsare used when approaching cancer?
Curative Chemotherapy
Leukemia, Lymphoma, Germ Cell Cancer
Adjuvant Chemotherapy Improve Survival After Surgical Resection
Improve Survival When Given With Radiation
a a ve emo erapy Relieve Pain, Dyspnea, Performance Status
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
18/31
Have a general understanding ofchemotherapy drugs by class
alkylators, anti-metabolites,topoisomerase inhibitors, microtubulen ng rugs, p a num ana ogues,
immune therapies, antibodies, tyrosine,
ec an sm o c on Metabolism
Toxicity
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
19/31
asses an ec an sms oChemotherapy Drugs
Alkylators: Cyclophosphamide, Nitrogen Mustard
Anti-metabolites: Fluorouracil (Capecitabine),
Cytarabine, Gemcitabine, Methotrexate, Fludarabine opo somerase n ors: oxoru c n, opos e,
Irinotecan
Microtubule Bindin Dru s: Vincas Taxanes
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
20/31
asses an ec an sms oChemotherapy Drugs
Immune Thera ies: Interferon IL-2
Antibodies: Trastuzumab, Cetuximab, Rituximab
TK Inhibitors: Erlotinib, Sunitinib, Lapatinib Platinum Compounds: Cisplatin, Carboplatin,
Oxaliplatin
ormona gen s: amox en, roma ase n ors(Anastrazole), LHRH Agonists
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
21/31
Metabolism of Chemotherapy Drugs
Primarily Renal Platinum Analogues, Methotrexate,
Bleomycin
Primarily Hepatic Taxanes, Vincas, Anthracyclines,
,
Primarily Intracellular 5-FU, Gemcitabine,
Cytarabine, Fludarabine
Also Prodrugs Cyclophosphamide, Capecitabine, Irinotecan,
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
22/31
Toxicity of Chemotherapy Drugs
Myelosuppression Common
xcept ons: ncr st ne, eomyc n, s,
Antibodies, Cisplatin
, ,
Nitrosureas
Renal Cisplatin
Neurotoxicity Vincristine, Taxanes, Cis-/Oxalo-platin
,
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
23/31
What is the role of palliative carein cancer treatment?
not just at the end
Relieve s m toms of disease and treatment
Focus on prognosis
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
24/31
cancer? How do they work?
Tobacco Cessation
Diet and Cancer
No evidence for supplements
Surgery to Prevent Cancer n cancer am y syn romes
Drugs to Prevent Cancer
Finasteride: Prostate Cancer
,
Vaccines to Prevent Cancer
Hepatitis B: Hepatocellular Cancer
Pa illoma Viruses: Cervical Head and Neck Cancers
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
25/31
effective? What makes a cancer
Definitely Effective Screens
Colonoscopy, Fecal Occult Blood for Colorectal Cancer
Pap Smear for Cervical Cancer Maybe Useful Screens
Chest CT in Smokers for Lung Cancer
Liver Scan/AFP in HB/CV(+) for Hepatoma
Definition of Effective Screen Reduces Morbidity and Mortality of Screened Cancer,
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
26/31
of cancer? Have a general sense of stages ofcancer.
Staging
Films, Physical Exam
Grading
Histology
Strong Prognostic Value
Strong Therapeutic Value
Some Prognostic Value
Little Therapeutic Value
Uses T, N, M System Uses Morphologic Guidelines
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
27/31
Staging Generalities
Stage I Small Tumor, Negative Nodes
Stage II Larger Tumor or Tumor Invades Deeper
Structures, Negative Nodes or Only Immediate Nodal
Grou
Stage III Larger Tumor or Positive Nodes
Stage IV Distant Metastatic Disease
There Are Exceptions To The Above Guide!
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
28/31
ow s pe atr c onco ogy erentfrom adult oncology?
Different Cancers
Few Carcinomas, More Leukemias
Prediliction for Cancer at Unique Ages Growth Spurts
Less Association With Environmental Factors
Cancer is Less Common
CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
29/31
What long term health issues mightsurvivors of cancer have to deal with?
Increased Risk of Second Cancers
,
?Elevated Genetic Risk?
Long-Term Side Effects of Treatment Chemotherapy Heart Failure, Leukemia, Sensory
Neuropathy, Renal Insufficiency, Sterility, Pulmonary
Fibrosis etc.
Radiation Dementia, Sarcomas, Leukemia, GrowthRetardation, Dry Mouth, Strictures, etc.
urgery ymp e ema, a a sorp on, a n enance o
Stomas, Dyspnea, etc.CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
30/31
ow can you exp a n erences n t eincidence of cancer around the world?
Different Environmental Exposures
n ec ons
HBV and Hepatoma in Asia
EBV and Burkitts Lymphoma in Africa Diets
Esophageal Cancer Belt Caspian Sea to China
Relatively New in Third World
Local Habits
e e u s
Access to Health Care
Cervical Cancer in Third World CC-Pieters & Liebmann Feb 11 2011
8/7/2019 cancer final review
31/31
Final Thoughts
Get a Good Nights Sleep
. ,
abstract idea
Obsess Less Over Trivia
Worry More About Understanding the Concepts
CC-Pieters & Liebmann Feb 11 2011